EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

A multicenter pilot study evaluating simplified central vein assessment for the diagnosis of multiple sclerosis

Lynn Daboul, Carly M O'Donnell, Moein Amin iD, Paulo Rodrigues, John Derbyshire, Christina Azevedo iD, Amit Bar-Or, Eduardo Caverzasi iD, Peter A Calabresi iD, Bruce Ac Cree iD, Leorah Freeman, Roland G Henry und 16 weitere

Multiple Sclerosis Journal · 2024

DOI: 10.1177/13524585231214360 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Multiple Sclerosis Journal, 2024. Verfasst von Lynn Daboul und 27 weiteren Autor:innen. Beteiligte Einrichtung: Translational Neuroradiology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA. Hauptthemen laut MEDLINE: Multiple Sclerosis. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIMH NIH HHS, Intramural NIH HHS, NINDS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The central vein sign (CVS) is a proposed magnetic resonance imaging (MRI) biomarker for multiple sclerosis (MS); the optimal method for abbreviated CVS scoring is not yet established.

Objective

The aim of this study was to evaluate the performance of a simplified approach to CVS assessment in a multicenter study of patients being evaluated for suspected MS.

Methods

Adults referred for possible MS to 10 sites were recruited. A post-Gd 3D T2*-weighted MRI sequence (FLAIR*) was obtained in each subject. Trained raters at each site identified up to six CVS-positive lesions per FLAIR* scan. Diagnostic performance of CVS was evaluated for a diagnosis of MS which had been confirmed using the 2017 McDonald criteria at thresholds including three positive lesions (Select-3*) and six positive lesions (Select-6*). Inter-rater reliability assessments were performed.

Results

Overall, 78 participants were analyzed; 37 (47%) were diagnosed with MS, and 41 (53%) were not. The mean age of participants was 45 (range: 19–64) years, and most were female ( n = 55, 71%). The area under the receiver operating characteristic curve (AUROC) for the simplified counting method was 0.83 (95% CI: 0.73–0.93). Select-3* and Select-6* had sensitivity of 81% and 65% and specificity of 68% and 98%, respectively. Inter-rater agreement was 78% for Select-3* and 83% for Select-6*.

Conclusion

A simplified method for CVS assessment in patients referred for suspected MS demonstrated good diagnostic performance and inter-rater agreement.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple SclerosisAdultHumansFemaleYoung AdultMiddle AgedMalePilot ProjectsReproducibility of ResultsVeinsMagnetic Resonance ImagingBrain

Stichwörter der Autor:innen

Central vein signFLAIR*MRIbiomarkersmultiple sclerosis

Autor:innen und Institutionen

  • Translational Neuroradiology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.
  • Cleveland Clinic Lerner College of Medicine, Cleveland, OH, USA.
  • Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
  • Neurological Institute, Cleveland Clinic, Cleveland, OH, USA.
  • QMENTA Cloud Platform, QMENTA Inc., Boston, MA, USA.
  • Functional MRI Facility, NIMH, National Institutes of Health, Bethesda, MD, USA.

ORCID-Profile: Moein Amin, Christina Azevedo, Eduardo Caverzasi, Peter A Calabresi, Bruce Ac Cree, Elias S Sotirchos, Daniel S Reich, Pascal Sati, Daniel Ontaneda

Förderung

  • NIMH NIH HHS
  • Intramural NIH HHS
  • NINDS NIH HHS
  • Race to Erase MS

Zitieren

APA

Daboul, L., O'Donnell, C. M., Amin, M., Rodrigues, P., Derbyshire, J., Azevedo, C., Bar-Or, A., Caverzasi, E., Calabresi, P. A., Cree, B. A., Freeman, L., Henry, R. G., Longbrake, E. E., Oh, J., Papinutto, N., Pelletier, D., Prchkovska, V., Raza, P., Ramos, M., …, & Ontaneda, D. (2024). A multicenter pilot study evaluating simplified central vein assessment for the diagnosis of multiple sclerosis. Multiple Sclerosis Journal. https://doi.org/10.1177/13524585231214360

Vancouver

Daboul L, O'Donnell CM, Amin M, Rodrigues P, Derbyshire J, Azevedo C, et al. A multicenter pilot study evaluating simplified central vein assessment for the diagnosis of multiple sclerosis. Multiple Sclerosis Journal. 2024. doi:10.1177/13524585231214360

BibTeX
@article{Daboul2024,
  author = {Daboul, Lynn and O'Donnell, Carly M and Amin, Moein and Rodrigues, Paulo and Derbyshire, John and Azevedo, Christina and Bar-Or, Amit and Caverzasi, Eduardo and Calabresi, Peter A and Cree, Bruce Ac and Freeman, Leorah and Henry, Roland G and Longbrake, Erin E and Oh, Jiwon and Papinutto, Nico and Pelletier, Daniel and Prchkovska, Vesna and Raza, Praneeta and Ramos, Marc and Samudralwar, Rohini D and Schindler, Matthew K and Sotirchos, Elias S and Sicotte, Nancy L and Solomon, Andrew J and Shinohara, Russell T and Reich, Daniel S and Sati, Pascal and Ontaneda, Daniel},
  title = {A multicenter pilot study evaluating simplified central vein assessment for the diagnosis of multiple sclerosis},
  journal = {Multiple Sclerosis Journal},
  year = {2024},
  doi = {10.1177/13524585231214360}
}
Kostenlos starten →